Smartleaf Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Smartleaf Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66	Closed	-$14.4K	–	3467
2026 Q1	$14.4K	Buy	66 +13	+25%	+$2.91K	﹤0.01%	2141
2025 Q4	$11.1K	Buy	53 +40	+308%	+$8.26K	﹤0.01%	2351
2025 Q3	$2.49K	Buy	+13	New	+$2.42K	﹤0.01%	2552
2025 Q2	–	Sell	-63	Closed	-$9.74K	–	2737
2025 Q1	$9.74K	Sell	63 -9	-13%	-$1.29K	﹤0.01%	1940
2024 Q4	$9.83K	Hold	72	–	–	﹤0.01%	1991
2024 Q3	$10.4K	Hold	72	–	–	﹤0.01%	1732
2024 Q2	$9.75K	Buy	72 +9	+14%	+$1.23K	﹤0.01%	1426
2024 Q1	$9.35K	Hold	63	–	–	﹤0.01%	1028
2023 Q4	$8.02K	Buy	+63	New	+$6.28K	﹤0.01%	797

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Smartleaf Asset Management's ASND Position: Q2 2026 in Review

Smartleaf Asset Management sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 66 shares — an estimated $14.4K sold.

Smartleaf Asset Management first reported a position in ASND in Q4 2023 and held it in 9 quarters. The position peaked at $14.4K in Q1 2026. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Smartleaf Asset Management reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
Smartleaf Asset Management sold 66 Ascendis Pharma A/S shares in Q2 2026, an estimated $14.4K.
Smartleaf Asset Management first reported a position in Ascendis Pharma A/S in Q4 2023 and held it in 9 quarters.
Smartleaf Asset Management's Ascendis Pharma A/S position peaked at $14.4K in Q1 2026.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.